R

Repligen Corp

D
RGEN
USD
-1.95
(-1.3359%)
Market Closed
10,434.00
Volume
1.489
EPS
-
Div Yield
-4,785.666600
P/E
8,066,055,841.96
Market Cap
Today
-1.3359%
1 Week
7.238%
1 Month
5.401%
6 Months
-14.167%
12 Months
-4.616%
Year To Date
-19.971%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
C
CRSP
1.15
(2.2656%)
USD
S
SGMO
0.645
(29.9304%)
USD
E
EDIT
-0.11
(-3.3537%)
USD
N
NSTG
(%)
USD
V
VCYT
0.78
(2.1317%)
USD
N
NVTA
(%)
USD
F
FATE
-0.24
(-8.6022%)
USD
A
ALLO
-0.015
(-0.4666%)
USD
A
ARWR
0.055
(0.2579%)
USD
A
ARCT
0.38
(2.0663%)
USD

Title:
Repligen Corp

Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
Do you need help or have a question?
Contact Us